Trial intelligence / Profile preview

Porcine Fibrin Sealant in Preventing Cervical Anastomotic Leakage After Esophagectomy

NCT03529266Phase 2Completed

Sponsor
Sun Yat-sen University
Start
Jun 2018
Primary completion
Mar 2019
Modality
Injectable Hydrogels, Implantable Devices, Implantable Hydrogels
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of porcine fibrin sealant in Anastomotic Leak (AL), sponsored by Sun Yat-sen University. Primary endpoint: Incidence of postoperative cervical anastomotic leakage at 3 months. Started Jun 2018; status: completed.

02

Drugs

porcine fibrin sealant
03

Conditions

Anastomotic Leak (AL)

Beyond the preview

Go deeper on NCT03529266.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03529266.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call